Precision for Medicine acquires Applied Immunology
Thursday, May 5, 2016
Precision for Medicine, part of the Precision Medicine Group, has acquired Applied Immunology, which focuses in the creation and delivery of custom cell-based and immunoassay solutions. Applied Immunology supports innovative and targeted therapeutics developers across all areas, ranging from immuno-oncology to rare diseases to biosimilars from research to post-approval. Applied Immunology’s client base includes some of the most pioneering new venture-backed startups, along with many major global pharmaceutical firms.
Applied Immunology strengthens and expands Precision’s specialty laboratory services in cell-based and immunoassays, and creates state-of-the-art laboratory access for Precision’s west coast biotechnology clients. Precision is an innovator in biomarker research with depth and expertise in genomics, bio-informatics, assay development, global specimen logistics and companion diagnostics. Recently, Precision acquired ACT Oncology, an industry leader in oncology clinical trials with experience conducting studies across all tumor types and hematology indications.
“The acquisition of Applied Immunology deepens our scientific expertise and moves us closer to our west coast clients, many of which are pursuing indications where an in-depth exploration of the immune system and immune response to drugs is paramount,” said Chad Clark, president, Precision for Medicine. “Applied Immunology has become the trusted provider of complex laboratory services for numerous innovators developing highly novel targeted therapeutics. Precision’s global laboratory infrastructure and deep expertise in oncology combined with Applied Immunology’s expertise in specialty assays creates a global solution for our customers pursuing immune therapeutics, including immuno-oncology.”
“Precision’s scale and expertise enable us to immediately offer global solutions to our customers,” said Rajiv Mahadevan, CEO of Applied Immunology. “Our clients will continue to receive access to renowned scientific talent and the customized approach on which our reputation has been built. Now we can deliver global solutions such as immune monitoring to support development needs worldwide while ensuring the same quality and scientific rigor they expect from us.”
Headquartered in Redwood City, California, Applied Immunology has a scientific team including immunogenicity expert Eugen Koren, M.D., Ph.D., and dendritic cell biology and immunotherapy expert Anita Mehta-Damani, Ph.D. The combination of Precision and Applied Immunology fortifies Precision’s goal of becoming the critical solution provider to help innovative life sciences companies succeed in this new era of biomarker-driven development of novel therapies, particularly those targeting oncology and the immune system. Precision for Medicine is building a dedicated Precision Medicine Research Organization, capitalizing on opportunities driven by dramatic advances in science and technology.